Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Stage type
1.1.3 Customer type
1.1.4 Therapeutic Area
1.1.5 Regional Scope
1.1.6 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.5.1 Approaches Used To Estimate The Market Size
1.5.1.1 Approach 1: Region Wise Market Estimation Using Bottom-Up Approach
1.5.1.2 Approach 2: Parent Market Analysis
1.5.1.3 Approach 3: Commodity Flow (Company Share Analysis)
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective - 1:
1.9.2 Objective - 2:
1.9.3 Objective - 3:
1.9.4 Objective - 4:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Small Molecule Innovators CDMO Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Impact of COVID-19 on Small Molecule Innovator CDMO Market
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Increasing demand for small molecule drug
3.4.1.2 Growing demand for small molecules in the oncology segment
3.4.1.3 Increasing pharmaceutical r&d investments
3.4.2 Market Restraint Analysis
3.4.2.1 StriNgent government Regulations
3.4.2.2 Compliance Issues with Outsourcing
3.5 Small Molecule Innovators CDMO Market Analysis Tools
3.5.1 Porter’s Five Forces Analysis
3.5.2 PESTEL Analysis
Chapter 4 Small Molecule Innovator CDMO Market: Product Segment Analysis
4.1 Small Molecule Innovators CDMO: Market Share Analysis, 2021 & 2030
4.2 Small Molecule API
4.2.1 Small molecule API, 2017 - 2030 (USD Million)
4.3 Small Molecule Drug Product
4.3.1 Small molecule drug product market, 2017 - 2030 (USD Million)
4.3.2 Oral solid dose
4.3.2.1 ORAL SOLID DOSE MARKET, 2017 - 2030 (USD Million)
4.3.3 Semi-solid dose
4.3.3.1 SEMI-SOLID DOSE MARKET, 2017 - 2030 (USD Million)
4.3.4 Liquid dose
4.3.4.1 Liquid Solid Dose Market, 2017 - 2030 (USD Million)
4.3.5 Others
4.3.5.1 Others market, 2017 - 2030 (USD Million)
Chapter 5 Small Molecule Innovators CDMO Market: Stage Type Segment Analysis
5.1 Small Molecule Innovators CDMO: Market Share Analysis, 2021 & 2030
5.2 Preclinical
5.2.1 preclinical market, 2017 - 2030 (USD Million)
5.3 Clinical
5.3.1 Clinical market, 2017 - 2030 (USD Million)
5.3.2 Phase I
5.3.2.1 phase I market, 2017 - 2030 (USD Million)
5.3.3 Phase II
5.3.3.1 phase ii market, 2017 - 2030 (USD Million)
5.3.4 Phase III
5.3.4.1 phase iiI market, 2017 - 2030 (USD Million)
5.4 Commercial
5.4.1 Commercial market, 2017 - 2030 (USD Million)
Chapter 6 Small Molecule Innovators CDMO Market: Customer Type Segment Analysis
6.1 Small Molecule Innovators CDMO: Market Share Analysis, 2021 & 2030
6.2 Pharmaceutical
6.2.1 Pharmaceutical market, 2017 - 2030 (USD Million)
6.2.2 Small
6.2.2.1 Small market, 2017 - 2030 (USD Million)
6.2.3 Medium
6.2.3.1 MEdium market, 2017 - 2030 (USD Million)
6.2.4 Large
6.2.4.1 large market, 2017 - 2030 (USD Million)
6.3 Biotechnology
6.3.1 Biotechnology market, 2017 - 2030 (USD Million)
Chapter 7 Small Molecule Innovators CDMO Market: Therapeutic Area Segment Analysis
7.1 Small Molecule Innovators CDMO: Market Share Analysis, 2021 & 2030
7.2 Cardiovascular Disease
7.2.1 Cardiovascular diseases market, 2017 - 2030 (USD Million)
7.3 Oncology
7.3.1 Oncology market, 2017 - 2030 (USD Million)
7.4 Respiratory Disorders
7.4.1 Respiratory disorders market, 2017 - 2030 (USD Million)
7.5 Neurology
7.5.1 Neurology market, 2017 - 2030 (USD Million)
7.6 Metabolic Disorders
7.6.1 Metabolic disorders market, 2017 - 2030 (USD Million)
7.7 Infectious Diseases
7.7.1 Infectious diseases market, 2017 - 2030 (USD Million)
7.8 Others
7.8.1 Others market, 2017 - 2030 (USD Million)
Chapter 8 Small Molecule Innovators CDMO Market: Regional Analysis
8.1 Small Molecule Innovators CDMO: Market Share Analysis, 2021 & 2030
8.2 North America
8.2.1 North America Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Germany Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.4.2 India
8.4.2.1 India Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Japan Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.4.4 China
8.4.4.1 China Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Australia Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.4.6 South Korea
8.4.6.1 South Korea Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.6 MEA
8.6.1 MEA Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
8.6.4 UAE
8.6.4.1 UAE Small Molecule Innovators CDMO market, 2017 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 Lonza Group Ltd.
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Service benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Patheon (Thermo Fisher Scientific, Inc.)
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Service benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Cambrex Corporation
9.1.3.1 Company overview
9.1.3.2 Service benchmarking
9.1.3.3 Strategic initiatives
9.1.4 CATALENT, INC.
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Service benchmarking
9.1.5 Siegfried Holding AG
9.1.5.1 Company overview
9.1.5.2 Financial performance
9.1.5.3 Service benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Recipharm AB
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Service benchmarking
9.1.6.4 Strategic initiatives
9.1.7 CordenPharma International
9.1.7.1 Company overview
9.1.7.2 Service benchmarking
9.1.7.3 Strategic initiatives
9.1.8 Boehringer Ingelheim
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Service benchmarking
9.1.8.4 Strategic initiatives
9.1.9 Piramal Pharma Solutions
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Service benchmarking
9.1.9.4 Strategic initiatives
9.1.10 Covance Inc.
9.1.10.1 Company overview
9.1.10.2 Financial performance
9.1.10.3 Service benchmarking
9.1.10.4 Strategic initiatives
9.2 Company Analysis
9.2.1 Heat Map Analysis of Competitors



List of Figures

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Small Molecule Innovators CDMO market snapshot (2021) (USD Million)
Fig. 9 Small Molecule Innovator market segmentation
Fig. 10 Parent market outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Porter’s five forces analysis
Fig. 15 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 16 Small Molecule Innovator CDMO market Product outlook: Segment dashboard
Fig. 17 Small Molecule Innovators CDMO market: Product movement analysis
Fig. 18 Small Molecule API market 2017 - 2030 (USD Million)
Fig. 19 Small Molecule Drug Product Market, 2017 - 2030 (USD Million)
Fig. 20 Oral solid dose Market, 2017 - 2030 (USD Million)
Fig. 21 Semi-solid dose Market, 2017 - 2030 (USD Million)
Fig. 22 Semi-Solid Dose Market, 2017 - 2030 (USD Million)
Fig. 23 Antibody drug conjugate market, 2017 - 2030 (USD Million)
Fig. 24 Small Molecule Innovators CDMO market synthesis outlook: segment dashboard
Fig. 25 Small Molecule Innovators CDMO market: Stage type movement analysis
Fig. 26 Preclinical market, 2017 - 2030 (USD Million)
Fig. 27 Clinical market, 2017 - 2030 (USD Million)
Fig. 28 Phase I market, 2017 - 2030 (USD Million)
Fig. 29 Phase II market, 2017 - 2030 (USD Million)
Fig. 30 Phase III market, 2017 - 2030 (USD Million)
Fig. 31 Commercial market, 2017 - 2030 (USD Million)
Fig. 32 Small Molecule Innovators CDMO market synthesis outlook: segment dashboard
Fig. 33 Small Molecule Innovators CDMO market: Customer type movement analysis
Fig. 34 Pharmaceutical market, 2017- 2030 (USD Million)
Fig. 35 Small market, 2017 - 2030 (USD Million)
Fig. 36 Medium market, 2017 - 2030 (USD Million)
Fig. 37 Large market, 2017 - 2030 (USD Million)
Fig. 38 Biotechnology market, 2017 - 2030 (USD Million)
Fig. 39 Small Molecule Innovators CDMO market synthesis outlook: segment dashboard
Fig. 40 Small Molecule Innovators CDMO market: Therapeutic area movement analysis
Fig. 41 Cardiovascular Disease market, 2017 - 2030 (USD Million)
Fig. 42 Oncology market, 2017 - 2030 (USD Million)
Fig. 43 Respiratory Disorders market, 2017 - 2030 (USD Million)
Fig. 44 Neurology market, 2017 - 2030 (USD Million)
Fig. 45 Metabolic disorders market, 2017 - 2030 (USD Million)
Fig. 46 Infectious diseases market, 2017 - 2030 (USD Million)
Fig. 47 Other’s market, 2017 - 2030 (USD Million)
Fig. 48 Regional market: Key takeaways
Fig. 49 Small Molecule Innovators CDMO market: Regional movement analysis
Fig. 50 North America market, 2017 - 2030 (USD Million)
Fig. 51 U.S. market, 2017 - 2030 (USD Million)
Fig. 52 Canada market, 2017 - 2030 (USD Million)
Fig. 53 Europe market, 2017 - 2030 (USD Million)
Fig. 54 U.K. market, 2017 - 2030 (USD Million)
Fig. 55 Germany market, 2017 - 2030 (USD Million)
Fig. 56 France market, 2017 - 2030 (USD Million)
Fig. 57 Italy market, 2017 - 2030 (USD Million)
Fig. 58 Spain market, 2017 - 2030 (USD Million)
Fig. 59 Asia Pacific market, 2017 - 2030 (USD Million)
Fig. 60 India market, 2017 - 2030 (USD Million)
Fig. 61 Japan market, 2017 - 2030 (USD Million)
Fig. 62 China market, 2017 - 2030 (USD Million)
Fig. 63 Australia market, 2017 - 2030 (USD Million)
Fig. 64 South Korea market, 2017 - 2030 (USD Million)
Fig. 65 Latin America market, 2017 - 2030 (USD Million)
Fig. 66 Brazil market, 2017 - 2030 (USD Million)
Fig. 67 Mexico market, 2017 - 2030 (USD Million)
Fig. 68 Argentina market, 2017 - 2030 (USD Million)
Fig. 69 MEA market, 2017 - 2030 (USD Million)
Fig. 70 South Africa market, 2017 - 2030 (USD Million)
Fig. 71 Saudi Arabia market, 2017 - 2030 (USD Million)
Fig. 72 UAE market, 2017 - 2030 (USD Million)
Fig. 73 Heat Map Analysis

List of Tables

List of Tables

Table 1 Global Small Molecule Innovator CDMO Market, by Region, 2017 - 2030 (USD Million)
Table 2 Global Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 3 Global Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 4 Global Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 5 Global Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 6 Global Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 7 Global Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 8 Global Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 9 Global Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 10 Global Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 11 Global Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 12 North America Small Molecule Innovator CDMO Market, by Region, 2017-2030, (USD Million)
Table 13 North America Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 14 North America Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 15 North America Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 16 North America Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 17 North America Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 18 North America Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 19 North America Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 20 North America Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 21 North America Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 22 North America Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 23 U.S. Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 24 U.S. Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 25 U.S. Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 26 U.S. Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 27 U.S. Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 28 U.S. Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 29 U.S. Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 30 U.S. Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 31 U.S. Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 32 U.S. Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 33 Canada Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 34 Canada Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 35 Canada Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 36 Canada Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 37 Canada Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 38 Canada Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 39 Canada Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 40 Canada Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 41 Canada Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 42 Canada Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 43 Europe Small Molecule Innovator CDMO Market, by Region, 2017-2030, (USD Million)
Table 44 Europe Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 45 Europe Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 46 Europe Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 47 Europe Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 48 Europe Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 49 Europe Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 50 Europe Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 51 Europe Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 52 Europe Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 53 Europe Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 54 U.K. Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 55 U.K. Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 56 U.K. Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 57 U.K. Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 58 U.K. Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 59 U.K. Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 60 U.K. Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 61 U.K. Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 62 U.K. Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 63 U.K. Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 64 Germany Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 65 Germany Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 66 Germany Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 67 Germany Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 68 Germany Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 69 Germany Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 70 Germany Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 71 Germany Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 72 Germany Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 73 Germany Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 74 France Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 75 France Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 76 France Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 77 France Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 78 France Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 79 France Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 80 France Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 81 France Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 82 France Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 83 France Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 84 Italy Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 85 Italy Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 86 Italy Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 87 Italy Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 88 Italy Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 89 Italy Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 90 Italy Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 91 Italy Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 92 Italy Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 93 Italy Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 94 Spain Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 95 Spain Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 96 Spain Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 97 Spain Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 98 Spain Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 99 Spain Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 100 Spain Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 101 Spain Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 102 Spain Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 103 Spain Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 104 APAC Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 105 APAC Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 106 APAC Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 107 APAC Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 108 APAC Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 109 APAC Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 110 APAC Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 111 APAC Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 112 APAC Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 113 APAC Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 114 India Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 115 India Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 116 India Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 117 India Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 118 India Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 119 India Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 120 India Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 121 India Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 122 India Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 123 India Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 124 Japan Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 125 Japan Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 126 Japan Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 127 Japan Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 128 Japan Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 129 Japan Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 130 Japan Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 131 Japan Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 132 Japan Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 133 Japan Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 134 China Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 135 China Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 136 China Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 137 China Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 138 China Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 139 China Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 140 China Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 141 China Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 142 China Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 143 China Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 144 Australia Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 145 Australia Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 146 Australia Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 147 Australia Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 148 Australia Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 149 Australia Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 150 Australia Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 151 Australia Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 152 Australia Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 153 Australia Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 154 South Korea Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 155 South Korea Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 156 South Korea Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 157 South Korea Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 158 South Korea Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 159 South Korea Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 160 South Korea Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 161 South Korea Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 162 South Korea Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 163 South Korea Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 164 Latin America Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 165 Latin America Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 166 Latin America Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 167 Latin America Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 168 Latin America Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 169 Latin America Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 170 Latin America Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 171 Latin America Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 172 Latin America Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 173 Latin America Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 174 Brazil Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 175 Brazil Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 176 Brazil Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 177 Brazil Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 178 Brazil Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 179 Brazil Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 180 Brazil Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 181 Brazil Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 182 Brazil Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 183 Brazil Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 184 Mexico Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 185 Mexico Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 186 Mexico Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 187 Mexico Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 188 Mexico Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 189 Mexico Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 190 Mexico Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 191 Mexico Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 192 Mexico Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 193 Mexico Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 194 Argentina Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 195 Argentina Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 196 Argentina Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 197 Argentina Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 198 Argentina Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 199 Argentina Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 200 Argentina Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 201 Argentina Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 202 Argentina Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 203 Argentina Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 204 MEA Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 205 MEA Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 206 MEA Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 207 MEA Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 208 MEA Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 209 MEA Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 210 MEA Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 211 MEA Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 212 MEA Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 213 MEA Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 214 South Africa Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 215 South Africa Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 216 South Africa Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 217 South Africa Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 218 South Africa Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 219 South Africa Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 220 South Africa Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 221 South Africa Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 222 South Africa Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 223 South Africa Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 224 Saudi Arabia Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 225 Saudi Arabia Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 226 Saudi Arabia Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 227 Saudi Arabia Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 228 Saudi Arabia Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 229 Saudi Arabia Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 230 Saudi Arabia Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 231 Saudi Arabia Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 232 Saudi Arabia Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 233 Saudi Arabia Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)
Table 234 UAE Small Molecule Innovator CDMO Market, by Product, 2017 - 2030 (USD Million)
Table 235 UAE Small Molecule Innovator CDMO Market, by Small Molecule Drug Product, 2017 - 2030 (USD Million)
Table 236 UAE Small Molecule Innovator CDMO Market, by Stage Type, 2017 - 2030 (USD Million)
Table 237 UAE Small Molecule Innovator CDMO Market, by Clinical, 2017 - 2030 (USD Million)
Table 238 UAE Small Molecule Innovator CDMO Market, by Phase I, 2017 - 2030 (USD Million)
Table 239 UAE Small Molecule Innovator CDMO Market, by Phase II, 2017 - 2030 (USD Million)
Table 240 UAE Small Molecule Innovator CDMO Market, by Phase III, 2017 - 2030 (USD Million)
Table 241 UAE Small Molecule Innovator CDMO Market, by Customer Type, 2017 - 2030 (USD Million)
Table 242 UAE Small Molecule Innovator CDMO Market, by Pharmaceutical, 2017 - 2030 (USD Million)
Table 243 UAE Small Molecule Innovator CDMO Market, by Therapeutic Area, 2017 - 2030 (USD Million)